146 related articles for article (PubMed ID: 23010272)
1. Design, synthesis and in vitro activities on anti-platelet aggregation of 4-methoxybenzene-1,3-isophthalamides.
Liu XJ; Shi XX; Zhong YL; Liu N; Liu K
Bioorg Med Chem Lett; 2012 Nov; 22(21):6591-5. PubMed ID: 23010272
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and the Evaluations in vitro Antiplatelet Aggregation Activities of 4-Ethoxyisophthalamides.
Liu XJ; Shi TE; Wang X; Wei TT; Meng X
Cardiovasc Hematol Agents Med Chem; 2015; 13(2):124-8. PubMed ID: 26695422
[TBL] [Abstract][Full Text] [Related]
3. [Design, synthesis of novel N, N'-bis-(halogenophenyl)-4- methoxybenzene-1, 3-disulfonamides and evaluation of their anti-platelet aggregation activity].
Li GA; Wang X; Meng X; Lin YB; Li X; Liu XJ
Yao Xue Xue Bao; 2015 Feb; 50(2):185-90. PubMed ID: 25975026
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, DNA-PK inhibition, anti-platelet activity studies of 2-(N-substituted-3-aminopyridine)-substituted-1,3-benzoxazines and DNA-PK and PI3K inhibition, homology modelling studies of 2-morpholino-(7,8-di and 8-substituted)-1,3-benzoxazines.
Ihmaid SK; Al-Rawi JM; Bradley CJ; Angove MJ; Robertson MN
Eur J Med Chem; 2012 Nov; 57():85-101. PubMed ID: 23059543
[TBL] [Abstract][Full Text] [Related]
5. [In vitro study of the mechanism of the platelet anti-aggregant action of picotamide (G 137)].
Berrettini M; De Cunto M; Romanelli A; Volpato I; Orzalesi G; Nenci GG
Boll Soc Ital Biol Sper; 1983 Mar; 59(3):309-15. PubMed ID: 9704127
[No Abstract] [Full Text] [Related]
6. Synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing a cleavable moiety with anti-platelet activity.
Yang XZ; Yang WH; Xu YG; Diao XJ; He GW; Gong GQ
Eur J Med Chem; 2012 Nov; 57():21-8. PubMed ID: 23043765
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of platelet aggregation inhibitory activity of some 3-phenyl-pyrroloquinazolinones.
Ferlin MG; Borgo C; Deana R
Eur J Med Chem; 2012 Feb; 48():275-83. PubMed ID: 22236469
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as platelet aggregation inhibitors.
Tian X; Wang LY; Xia S; Li ZB; Liu XH; Yuan Y; Fang L; Zuo H
Bioorg Med Chem Lett; 2012 Jan; 22(1):204-6. PubMed ID: 22137848
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation as platelet aggregation inhibitors of 6-phenyl-2,4-substituted-3(2H)-pyridazinones and their rigid analogues benzo[h]cinnolin-3,5-diones.
Dal Piaz V; Ciciani G; Giovannoni MP
Drug Des Discov; 1996 Mar; 14(1):53-75. PubMed ID: 8854045
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis of thienopyridine derivatives and its anti-platelet activity in vivo].
Zhou YS; Wang PB; Liu Y; Chen JF; Yue N; Liu DK
Yao Xue Xue Bao; 2011 Jan; 46(1):70-4. PubMed ID: 21465811
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 2,3-disubstituted 1,4-naphthoquinones as antiplatelet agents.
Lien JC; Wu CR; Hour MJ; Huang LJ; Huang TF; Kuo SC
Arch Pharm (Weinheim); 2008 Oct; 341(10):639-44. PubMed ID: 18720342
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
[TBL] [Abstract][Full Text] [Related]
15. Derivatives of 7-amino-1,2,3,4-tetrahydroisoquinoline and isophthalic acids as novel fibrinogen receptor antagonists.
Malovichko OL; Petrus AS; Krysko AA; Kabanova TA; Andronati SA; Karaseva TL; Kiriyak AV
Bioorg Med Chem Lett; 2006 Oct; 16(20):5294-7. PubMed ID: 16919941
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new 4,5-3(2H)pyridazinone derivatives and their cardiotonic, hypotensive, and platelet aggregation inhibition activities.
Amin EN; Abdel-Alim AA; Abdel-Moty SG; El-Shorbagi AN; Abdel-Rahman MSh
Arch Pharm Res; 2010 Jan; 33(1):25-46. PubMed ID: 20191341
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and inhibition of platelet aggregation for some 1-o-chlorophenyl-1,2,3,4-tetrahydroisoquinoline derivatives.
Yang J; Hua WY; Wang FX; Wang ZY; Wang X
Bioorg Med Chem; 2004 Dec; 12(24):6547-57. PubMed ID: 15556771
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and anti-platelet activity of obovatol derivatives.
Kwak JH; Lee S; Park ES; In JK; Song J; Kim YJ; Choi NS; Lee H; Yun YP; Hong JT; Kwak YS; Min KH; Jung JK
Arch Pharm Res; 2011 Jul; 34(7):1107-12. PubMed ID: 21811917
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs.
Hsieh PW; Chiang SZ; Wu CC; Lo YC; Shih YT; Wu YC
Bioorg Med Chem; 2008 May; 16(10):5803-14. PubMed ID: 18407506
[TBL] [Abstract][Full Text] [Related]
20. New platelet aggregation inhibitors based on pyridazinone moiety.
Costas T; Costas-Lago MC; Vila N; Besada P; Cano E; TerĂ¡n C
Eur J Med Chem; 2015 Apr; 94():113-22. PubMed ID: 25757094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]